Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of increased versus standard dosage of Dymista nasal spray in persistent allergic rhinitis
TCTR20250502001Phase 2Unknown
- Sponsor
- Faculty of Medicine, Chulalongkorn University
- Start
- Sep 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluticasone propionate in allergic rhinitis (AR), sponsored by Faculty of Medicine, Chulalongkorn University. Status: unknown.
02
Drugs
fluticasone propionate
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on TCTR20250502001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250502001.